Achillion Pharmaceuticals, Inc. (ACHN) to Present at the 2012 Wedbush Pacgrow Lifesciences Management Access Conference
8/10/2012 9:31:25 AM
NEW HAVEN, Conn., Aug. 10, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that Michael Kishbauch, President and Chief Executive Officer of Achillion, will present a corporate overview at the 2012 Wedbush Pacgrow Lifesciences Management Access Conference. The presentation will take place at Le Parker Meridien Hotel in New York, NY on Tuesday, August 14, 2012 at 12:45 p.m. EDT.
comments powered by